Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness

Background: The BRAF(V600E) mutation is the most common somatic mutation in thyroid cancer. The mechanism associated with BRAF-mutant tumor aggressiveness remains unclear. Lysyl oxidase (LOX) is highly expressed in aggressive thyroid cancers, and involved in cancer metastasis. The objective was to d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid
Main Authors: Boufraqech, Myriem, Patel, Dhaval, Nilubol, Naris, Powers, Astin, King, Timothy, Shell, Jasmine, Lack, Justin, Zhang, Lisa, Gara, Sudheer Kumar, Gunda, Viswanath, Klubo-Gwiezdzinska, Joanna, Kumar, Suresh, Fagin, James, Knauf, Jeffrey, Parangi, Sareh, Venzon, David, Quezado, Martha, Kebebew, Electron
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2019
Assuntos:
Thyroid Cancer and Nodules
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352555/
https://ncbi.nlm.nih.gov/pubmed/30398411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2018.0424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados